Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prestige Brand Holdings (NY: PBH )

71.80 +1.15 (+1.63%)
Official Closing Price Updated: 7:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 234,234
Open 71.34
Bid (Size) 71.36 (1)
Ask (Size) 72.14 (1)
Prev. Close 70.65
Today's Range 70.49 - 71.93
52wk Range 56.34 - 75.31
Shares Outstanding 50,059,989
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga

Performance

YTD
+15.83%
+15.83%
1 Month
+10.70%
+10.70%
3 Month
+5.50%
+5.50%
6 Month
+21.59%
+21.59%
1 Year
+21.24%
+21.24%

More News

Read More
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For February 8, 2024
Via Benzinga
Earnings Scheduled For August 3, 2023
Via Benzinga
Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
PBH Stock Earnings: Prestige Consumer Misses EPS, Misses Revenue for Q4 2024
Via InvestorPlace
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For March 15, 2024
Via Benzinga
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
Via Talk Markets
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Earnings Scheduled For August 14, 2023
Via Benzinga
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
From Prestige Consumer Healthcare Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.